Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01741909

Reducing Cost of Azythromycin by Transferring From IV to Oral Therapy

Can the Cost of Azythromycin in be Reduced in Hospitalized Patients With Community Acquired Pneumonia by Quick Transfer From Intravenous to Oral Therapy?

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
HaEmek Medical Center, Israel · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Intravenous Azythromycin therapy is considerably more expensive than oral therapy. The investigators believe that intravenous therapy is prolonged more that necessary and that oral therapy can be used much earlier in the course of the disease. The investigators plan to check if that statement is true and intervene in order to shorten the intravenous therapy.

Detailed description

The study will be performed in two stages. First a retrospective review of medical files of 50 patients hospitalized in the Haemek Medical Center with severe community acquired pneumonia, treated with azythromycin. The files will be reviewed for the criteria clinical improvement, and for azythromycin therapy, oral or intravenous. The results of this review will help us define the appropriate behavioral intervention in order to cause doctors to transfer from IV to PO therapy at the earliest appropriate time. An intervention such as posters, pharmacy overseeing etc will be introduced. 3 months after the intervention, an additional 50 files of pneumonia patients treated with azythromycin will be reviewed in order to check the efficacy of the intervention. The Review board and the NIH will be updated about the intervention, as soon as the investigators have decided what intervention is appropriate

Conditions

Interventions

TypeNameDescription
BEHAVIORALeducationafter a baseline period, shorter intravenous treatment will be promoted by mail, posters, lectures, and pharmacy monitoring of treatment

Timeline

Start date
2012-12-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2012-12-05
Last updated
2016-08-31

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01741909. Inclusion in this directory is not an endorsement.